The Delhi High Court has ruled in favour of Pharmacyclics LLC and Johnson & Johnson Pvt Ltd (Johnson & Johnson) in a patent infringement suit moved by them for violation of their rights in targeted cancer treatment drug, Ibrutinib, marketed as Imbruvica. Find out all about the case here.
Read Full ArticleSC expunges Allahabad HC’s remark about ‘majority becoming minority’ in bail case related to forcible religious conversion and abduction.
28 September, 2024 03:53 PM